(Q51992511)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858457%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Detecting cognitive dysfunction in multiple sclerosis with a magnetic resonance imaging rating scale: a pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858457%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

main subject

cognitive dysfunction

1 reference

4

Sandra E Black

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858457%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Laury Chamelian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858457%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Christian Bocti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858457%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Fu-Qiang Gao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858457%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Anthony Feinstein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858457%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858457%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858457%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858457%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858457%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

394-401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858457%20AND%20SRC:MED&resulttype=core&format=json

A short review of cognitive and functional neuroimaging studies of cholinergic drugs: implications for therapeutic potentials

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Gist recall in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Anterograde and Retrograde Amnesia in Patients With Chronic Progressive Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Deficient learning and memory in early and middle phases of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Depression in multiple sclerosis: relationship to planning ability

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Paced auditory serial-addition task: a measure of recovery from concussion

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Memory disturbance in chronic progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Evaluating storage, retention, and retrieval in disordered memory and learning

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Structural brain abnormalities in multiple sclerosis patients with major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Executive function in multiple sclerosis. The role of frontal lobe pathology

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Neuropsychological and structural brain lesions in multiple sclerosis: A regional analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Cognition in patients with multiple sclerosis After four years.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Clinical and demographic predictors of cognitive performance in multiple sclerosis. Do diagnostic type, disease duration, and disability matter?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Neuropsychological effects of interferon ?-1a in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Disability and intellectual function in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

The prevalence of cognitive impairment in a community survey of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Donepezil improved memory in multiple sclerosis in a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Neuropsychological aspects of multiple sclerosis: a quantitative review

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Development and Validation of a Model for Estimating Premorbid Verbal Intelligence in the Elderly

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Guidelines for neuropsychological research in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Automatic memory processes in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. A psychometric and MRI study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Magnetic resonance imaging correlates of dementia in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Cognitive impairment in patients with multiple sclerosis and mild physical disability.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

Cognitive dysfunction in multiple sclerosis: a review of recent developments

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022768

7 January 2021

10.1017/S1092852900022768

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858457%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference